Cheryl L. Willman
Willman, Cheryl L.
VIAF ID: 72983265 (Personal)
Permalink: http://viaf.org/viaf/72983265
Preferred Forms
- 100 0 _ ‡a Cheryl L. Willman
-
- 100 1 _ ‡a Willman, Cheryl L
-
- 100 1 _ ‡a Willman, Cheryl L. (sparse)
-
- 100 1 0 ‡a Willman, Cheryl L.
4xx's: Alternate Name Forms (1)
Works
Title | Sources |
---|---|
Heterogeneity in CBF beta/MYH11 fusion messages encoded by the inv(16)(p13q22) and the t(16;16)(p13;q22) in acute myelogenous leukemia | |
High Frequency and Poor Outcome of Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia in Adults | |
HRX involvement in de novo and secondary leukemias with diverse chromosome 11q23 abnormalities | |
Hypergranular promyelocytic leukemia: correlation between morphology and chromosomal translocations including t(15;17) and t(11;17). | |
Identification of gene expression profiles that segregate patients with childhood leukemia | |
Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome | |
Impact of Specimen Heterogeneity on Biomarkers in Repository Samples from Patients with Acute Myeloid Leukemia: A SWOG Report. | |
Induction of apoptosis in retinoid-refractory acute myelogenous leukemia by a novel AHPN analog. | |
Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse | |
Integrin α6 mediates drug resistance of acute lymphoblastic B-cell leukemia | |
Intensified chemotherapy without SCT in infant ALL: results from COG P9407 (Cohort 3) | |
Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study | |
Lack of IRF-1 expression in acute promyelocytic leukemia and in a subset of acute myeloid leukemias with del(5)(q31). | |
Malignant progenitors from patients with acute myelogenous leukemia are sensitive to a diphtheria toxin-granulocyte-macrophage colony-stimulating factor fusion protein. | |
Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations | |
Metnase mediates chromosome decatenation in acute leukemia cells | |
Mevastatin can increase toxicity in primary AMLs exposed to standard therapeutic agents, but statin efficacy is not simply associated with ras hotspot mutations or overexpression | |
Microsatellite instability is not a defining genetic feature of acute myeloid leukemogenesis in adults: results of a retrospective study of 132 patients and review of the literature | |
Molecular analysis and clinical outcome of adult APL patients with the type V PML-RARalpha isoform: results from intergroup protocol 0129 | |
Molecular diagnostics in pathology, c1991: | |
Multidrug resistance-1 (MDR1) expression and functional dye/drug efflux is highly correlated with the t(8;21) chromosomal translocation in pediatric acute myeloid leukemia | |
Multiparameter analysis of acute mixed lineage leukemia: correlation of a B/myeloid immunophenotype and immunoglobulin and T-cell receptor gene rearrangements with the presence of the Philadelphia chromosome translocation in acute leukemias with mye | |
Mutations of the myeloid transcription factor CEBPA are not associated with the blast crisis of chronic myeloid leukaemia. | |
A new human natural killer leukemia cell line, IMC-1. A complex chromosomal rearrangement defined by spectral karyotyping: functional and cytogenetic characterization | |
Novel FLT3 point mutations within exon 14 found in patients with acute myeloid leukaemia. | |
Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations | |
Optimizing the use of telemedicine in oncology care: post-pandemic opportunities | |
Outcome for pediatric acute promyelocytic leukemia patients at Children's Oncology Group sites on the Leukemia Intergroup Study CALGB 9710 (Alliance) | |
p73 mutations and expression in adult de novo acute myelogenous leukemia | |
A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403 | |
A phase I study of induction chemotherapy for older patients with newly diagnosed acute myeloid leukemia (AML) using mitoxantrone, etoposide, and the MDR modulator PSC 833: a southwest oncology group study 9617. | |
PK11195, a peripheral benzodiazepine receptor ligand, chemosensitizes acute myeloid leukemia cells to relevant therapeutic agents by more than one mechanism | |
Polymorphisms in DNA repair genes and therapeutic outcomes of AML patients from SWOG clinical trials. | |
Potent obatoclax cytotoxicity and activation of triple death mode killing across infant acute lymphoblastic leukemia | |
Pre-B acute lymphoblastic leukemia with b3a2 (p210) and e1a2 (p190) BCR-ABL fusion transcripts relapsing as chronic myelogenous leukemia with a less differentiated b3a2 (p210) clone | |
Pre-clinical validation of a novel, highly sensitive assay to detect PML-RARalpha mRNA using real-time reverse-transcription polymerase chain reaction | |
The presence of bcl-1 and bcl-2 gene rearrangements in diffuse small cleaved-cell lymphoma. A disease with diverse molecular and immunophenotypic findings | |
A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis | |
Prognostic implications of the IDH1 synonymous SNP rs11554137 in pediatric and adult AML: a report from the Children's Oncology Group and SWOG | |
The prognostic significance of IRF8 transcripts in adult patients with acute myeloid leukemia | |
Quantitative, real-time polymerase chain reactions for FLT3 internal tandem duplications are highly sensitive and specific | |
Randomized assessment of delayed intensification and two methods for parenteral methotrexate delivery in childhood B-ALL: Children's Oncology Group Studies P9904 and P9905 | |
Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia | |
Regularization strategies for hyperplane classifiers: application to cancer classification with gene expression data | |
Relapse of acute promyelocytic leukemia with PML-RARalpha mutant subclones independent of proximate all-trans retinoic acid selection pressure | |
Resolution of ambiguous low-level positive quantitative polymerase chain reaction results in TEL-AML1 positive ALL using a post-PCR fluorescent oligoligation method | |
A retrospective study of 69 patients with t(6;9)(p23;q34) AML emphasizes the need for a prospective, multicenter initiative for rare ‘poor prognosis’ myeloid malignancies | |
Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia | |
Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia. | |
Robust Methods for Microarray Analysis | |
Sequential phase II Southwest Oncology Group studies (S0112 and S0301) of daunorubicin and cytarabine by continuous infusion, without and with ciclosporin, in older patients with previously untreated acute myeloid leukaemia | |
SH2B3: a new leukemia predisposition gene | |
Signalling thresholds and negative B-cell selection in acute lymphoblastic leukaemia | |
SOX4 enables oncogenic survival signals in acute lymphoblastic leukemia | |
Targetable kinase gene fusions in high-risk B-ALL: a study from the Children's Oncology Group | |
The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers. | |
Targeting JAK1/2 and mTOR in murine xenograft models of Ph-like acute lymphoblastic leukemia | |
Treatment-influenced associations of PML-RARα mutations, FLT3 mutations, and additional chromosome abnormalities in relapsed acute promyelocytic leukemia | |
Treatment of children with acute promyelocytic leukemia: results of the first North American Intergroup trial INT0129 | |
Trisomy 11: an association with stem/progenitor cell immunophenotype | |
Trisomy 6 as a primary karyotypic aberration in hematologic disorders | |
Tyrosine kinome sequencing of pediatric acute lymphoblastic leukemia: a report from the Children's Oncology Group TARGET Project | |
Very late antigen-4 function of myeloblasts correlates with improved overall survival for patients with acute myeloid leukemia | |
VPREB1 deletions occur independent of lambda light chain rearrangement in childhood acute lymphoblastic leukemia. |